Glycerol Phenylbutyrate Oral Liquid
Amgen Inc.
Open FDA's page for this record- Discontinued date
- 09/01/2026
- Update type
- New
- Initial posting date
- 09/01/2026
- Package NDC
- 75987-050-07
- Generic name
- Glycerol Phenylbutyrate Oral Liquid
- Contact info
- 800-772-6436
- Related info
- Discontinuation in the manufacturing of the drug product
- Update date
- 09/01/2026
- Presentation
- RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07)
- Company name
- Amgen Inc.
- Status
- To Be Discontinued
- Therapeutic category
- Inborn Errors
- Harmonized identifiers (openFDA)
- Application number
- NDA203284
- Brand name
- RAVICTI
- Generic name
- GLYCEROL PHENYLBUTYRATE
- Manufacturer name
- Horizon Therapeutics USA, Inc.
- Product NDC
- 75987-050
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- GLYCEROL PHENYLBUTYRATE
- RxCUI
- 1368453, 1368459
- SPL ID
- a58b617c-635a-4a67-9f27-f9c93f8cba22
- SPL set ID
- 900e7dc0-9afe-4f50-80de-90567bb78519
- Package NDC
- 75987-050-06, 75987-050-07
- UNII
- ZH6F1VCV7B